Jonathan Shults, MD
Orthopaedic Surgery · Savannah, GANPI 1013013101
Payments from drug & device makers
Across 107 payments — averaging $57.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$3K
- Team 1, LLC$1K
- Arthrex$1K
- Linvatec Corporation$278
- Baudax Bio Inc.$201
- Axogen$182
- plus $660 from 21 others
What the payments were for
- Travel & lodging$1,88931%
- Food & beverage$4,26369%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 50 | $2,566 |
| Team 1, LLC | 9 | $1,264 |
| Arthrex | 14 | $1,001 |
| Linvatec Corporation | 1 | $278 |
| Baudax Bio Inc. | 6 | $201 |
| Axogen | 3 | $182 |
| Biorez, Inc. | 1 | $106 |
| Ortho Development Corporation | 1 | $74 |
| Stryker | 1 | $56 |
| Sonex Health, Inc. | 1 | $51 |
| Medacta USA, Inc. | 1 | $47 |
| Zyla Life Sciences, Inc. | 2 | $40 |
| Pacira Pharmaceuticals Incorporated | 2 | $33 |
| Amgen | 2 | $32 |
| Johnson & Johnson | 1 | $29 |
| Flower Orthopedics Coporation | 1 | $24 |
| IBSA Pharma Inc. | 1 | $22 |
| Medtronic | 1 | $20 |
| Pfizer | 1 | $20 |
| Bioventus LLC | 1 | $17 |
| KCI USA, Inc. | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Endo Pharmaceuticals Inc. | 1 | $13 |
| Forte Bio-pharma LLC | 1 | $13 |
| Zimmer Biomet | 1 | $13 |
| Vericel Corporation | 1 | $11 |
| Dynasplint Systems Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Latarjet System$410
- Q-FIX$410
- BioBrace 23mm$384
- Legion$252
- Regeneten$219
- MULTIFIX S$219
- Bioinductive Implant with Arthroscopic Delivery System - Medium$149
- Journey II$146
- AVANCE NERVE GRAFT$143
- Ascension$143
- Hat-Trick$143
- REAL INTELLIGENCE$126
- Navio Surgical System$111
- Journey II BCS$111
- BioBrace 5mm$106
How this compares
$6,151 in reported general payments places this provider in the 60th percentile of 654 orthopaedic surgery providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 219 | $2,993 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 24 | $158 |
| Meloxicam | 80 | $124 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Savannah
- Jonathan ChristySavannah$216K
- Charles HopeSavannah$121K
- Paul BalthropSavannah$83K
- Charles DecookCumming$48.3M
- Ormonde MahoneyAthens$10.8M
- Daxes BanitWarner Robins$5.7M
- John DorchakColumbus$3.8M
- Daniel SilcoxAtlanta$3.4M
- Dennis DevitoAtlanta$1.5M
- George GuildCumming$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.